British American Tobacco p.l.c. (LON:BATS – Get Free Report) hit a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 30.79 ($0.39) and last traded at GBX 3,054 ($38.53), with a volume of 23765799 shares trading hands. The stock had previously closed at GBX 3,090 ($38.98).
Analysts Set New Price Targets
Separately, JPMorgan Chase & Co. reiterated a “neutral” rating and set a GBX 2,800 ($35.32) price target on shares of British American Tobacco in a research report on Thursday, December 12th.
Check Out Our Latest Research Report on BATS
British American Tobacco Price Performance
British American Tobacco (LON:BATS – Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported GBX 364.30 ($4.60) earnings per share (EPS) for the quarter. British American Tobacco had a negative net margin of 52.84% and a negative return on equity of 25.94%. On average, equities analysts anticipate that British American Tobacco p.l.c. will post 361.5079365 EPS for the current year.
British American Tobacco Increases Dividend
The firm also recently disclosed a dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, December 19th were issued a GBX 58.88 ($0.74) dividend. This represents a yield of 2.54%. The ex-dividend date was Thursday, December 19th. This is a boost from British American Tobacco’s previous dividend of $57.72. British American Tobacco’s dividend payout ratio is -38.08%.
About British American Tobacco
BAT was founded in 1902 and was first listed on the London Stock Exchange in 1912. A constituent of the FTSE 100 since its creation in 1984, we have evolved, becoming the only truly global company in our sector.
BAT is transforming and is well positioned with a global footprint and multi-category portfolio.
Featured Stories
- Five stocks we like better than British American Tobacco
- What is a Low P/E Ratio and What Does it Tell Investors?
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- With Risk Tolerance, One Size Does Not Fit All
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- How to Profit From Growth Investing
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for British American Tobacco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for British American Tobacco and related companies with MarketBeat.com's FREE daily email newsletter.